Upcoming Meetings: Design control teleconference
This article was originally published in The Gray Sheet
Executive Summary
Design control teleconference: Joint FDA/Food and Drug Law Institute video teleconference to be held March 12 on design control requirements of FDA's quality systems regulation. FDAers scheduled to participate include Kimberly Trautman, good manufacturing practices QS expert in FDA's device center, and Joann Barron, a staffer in Division of Enforcement III in the device center's Office of Compliance. For more information, contact FDA at 888/361-4011 or FDLI's Meghan Smith at 202/371-0649...
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.